NCT00074438View on ClinicalTrials.gov

Study to Assess the Efficacy and Safety of Rituximab in Patients With Rheumatoid Arthritis

PHASE2CompletedINTERVENTIONAL

Enrollment

465

Participants

Timeline

Start Date

June 30, 2003

Primary Completion Date

September 30, 2004

Study Completion Date

July 31, 2011

Conditions

Rheumatoid Arthritis

Interventions

DRUG

methotrexate

Oral or parenteral repeating dose

DRUG

rituximab

Intravenous repeating dose

DRUG

corticosteroids

Intravenous repeating dose

DRUG

placebo

Intravenous repeating dose

Sponsors

Lead Sponsor

Genentech, Inc.

All Listed Sponsors

collaborator

Roche Pharma AG

INDUSTRY

lead

Genentech, Inc.

INDUSTRY